Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Profileringsgevoeligheid voor gerichte therapieën …
JoVE Journal
Cancer Research

This content is Free Access.

JoVE Journal Cancer Research
Profileringsgevoeligheid voor gerichte therapieën in EGFR-mutante NSCLC-patiënt-afgeleide organoïden
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Journal (Cancer Research)
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
Journal (Cancer Research)
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
 
Click here for the English version

Profileringsgevoeligheid voor gerichte therapieën in EGFR-mutante NSCLC-patiënt-afgeleide organoïden

Article DOI: 10.3791/63039-v • 08:52 min • November 22nd, 2021
November 22nd, 2021 •
1,2,3, 1,2, 1,2,3, 1,2,3
1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Dit protocol beschrijft een gestandaardiseerde evaluatie van geneesmiddelgevoeligheden voor gerichte signaleringsremmers in NSCLC-patiënt-afgeleide organoïdemodellen.

Tags

Kankeronderzoek Nummer 177 Organoïde longorganoïde BOB NSCLC longkanker osimertinib EGFR gerichte remmer resistentie
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter